Demo mode · This is a sample analysis for Atlas AI Inc. — upload your own agreement

Dashboard

Atlas AI Inc.

52

/ 100

Governance score

At risk

Unanimous approval required for key decisions

Art. 8.3

Article 8.3 requires unanimous shareholder approval for any new fundraise, board changes, and strategic pivots. With 3 founders, any one of them can block the company's most critical decisions.

No involuntary leaver clause for COO

Art. 12

Sam Brooks' shares are not subject to a good/bad leaver mechanism. If he leaves before vesting is complete, the company cannot buy back his shares at a reduced valuation.

Founding team — Atlas AI Inc.

Adam Reed40%

CEO & Co-Founder

Lina Carter35%

CTO & Co-Founder

Sam Brooks25%

COO & Co-Founder

Vesting timeline

Adam

Cliff — January 15, 2024

Fully vested — January 15, 2027

Lina

Cliff — January 15, 2024

Fully vested — January 15, 2027

Sam

Cliff — January 15, 2024

Fully vested — January 15, 2026

Who approves what

New fundraise (Series A+)

Unanimous
Adam+Lina+Sam

Any founder can block a raise.

Hire C-level executives

Majority
Adam+Lina+Sam

Approve annual budget

Board
Board

Amend the SHA

Unanimous
Adam+Lina+Sam

Deadlock risk if founders disagree.

IP assignment & licensing

Single
CEO

Rules of your company

AtlasAI_SHA_2023.pdf

Vesting schedule

4 years, 1-year cliff for Reed & Carter. 3 years for Brooks.

✓ Present

Good/bad leaver provisions

Present for Reed & Carter. Missing for Brooks.

⚠ Risk

Drag-along rights

60% majority can force a sale.

✓ Present

Tag-along rights

Minority shareholders protected in any transfer.

✓ Present

Anti-dilution protection

Not found. Founders are exposed in down rounds.

✗ Missing

Unanimous approval clauses

Required for 5 critical decisions — creates deadlock risk.

⚠ Risk

Non-compete clause

24-month non-compete post-departure.

✓ Present

Deadlock resolution

Mediation mentioned but no binding mechanism defined.

? Unclear

Atlas AI Inc. has a solid vesting structure for two of its three founders, but the unanimous approval requirement across 5 critical decisions is a significant governance risk. The missing anti-dilution clause and incomplete leaver provisions for Sam Brooks are high-priority gaps to address before Series A.

Explore this demo